IA-0130, a novel 3-(1,3-diarylallylidene)oxindole derivative, alleviates ovarian cancer via inhibiting IL-6/gp130/STAT3 signalling
- Sun Ae Park
- , Hee Jung Kim
- , Lee Kyung Kim
- , Hae Ri Lee
- , Bo Kyung Jung
- , Ji Hyeon Kim
- , Myung Jin Kim
- , Tae Gwon Oh
- , Hee Eun Kang
- , Kye Jung Shin
- , Jae Hong Seo
- , Tae Hwe Heo
- The Catholic University of Korea
- Ltd.
Research output: Contribution to journal › Article › peer-review
2
Scopus
citations